美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Bristol-Myers Squibb Co.

801.01

0.0000

成交量：- -

成交額：- -

市值：219.88萬

市盈率：398.51

高：801.01

開：801.01

低：801.01

收：801.01

52周最高：1,225.00

52周最低：735.50

股本：2,745.00

流通股本：2,745.00

量比：0.07

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):2.01

每股收益(LYR):2.02

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):397.13

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Bristol-Myers Squibb Co.

交易所：

PINK LIMITED

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.bms.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

百時美施貴寶公司於1933年8月根據特拉華州法律註冊成立，名為百時美公司，繼承了1887年在紐約成立的一家企業。1989年，由於合併，公司更名為百時美施貴寶公司。該公司在全球範圍內從事生物製藥產品的發現、開發、許可、製造、營銷、分銷和銷售。該公司預計，對Celgene和MyoKardia的收購將進一步將公司定位為領先的生物製藥公司，通過幾項近期資產和額外的外部合作夥伴關係擴大其腫瘤學、血液學、免疫學和心血管領域的投資組合。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BMYMP/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMYMP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMYMP\",,,,,undefined,":{"symbol":"BMYMP","market":"US","secType":"STK","nameCN":"Bristol-Myers Squibb Co.","latestPrice":801.01,"timestamp":1756497600000,"preClose":801.01,"halted":0,"volume":0,"delay":15,"floatShares":2745,"shares":2745,"eps":2.01,"marketStatus":"勞工日休市","change":0,"latestTime":"08-29 16:00:00 EDT 延時","open":801.01,"high":801.01,"low":801.01,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":2.01,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1756800000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":801.01,"volumeRatio":0.068026863808518},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMYMP\",,,,,undefined,":{"symbol":"BMYMP","floatShares":2745,"roa":"--","roe":"--","lyrEps":2.017008,"volumeRatio":0.068026863808518,"shares":2745,"dividePrice":0,"high":801.01,"amplitude":0,"preClose":801.01,"low":801.01,"week52Low":735.5,"pbRate":"--","week52High":1225,"institutionHeld":0,"latestPrice":801.01,"eps":2.01,"divideRate":0,"volume":0,"delay":15,"ttmEps":2.01,"open":801.01,"prevYearClose":998.89,"prevWeekClose":801.01,"prevMonthClose":801.01,"prevQuarterClose":801.01,"fiveDayClose":809.5,"twentyDayClose":785,"sixtyDayClose":898.98},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMYMP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-06","symbol":"BMYMP","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"","actualEps":null},{"date":"2024-07-26","symbol":"BMYMP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1721980800000,"name":null,"time":"盤前","dateTimestamp":1721966400000,"actualEps":null},{"market":"US","date":"2024-04-25","symbol":"BMYMP","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"pre","actualEps":null},{"date":"2023-07-31","symbol":"BMYMP","amount":0.5,"announcedDate":"2023-06-15","type":"dividend","market":"US","newRecordDate":"2023-08-01","defaultRemindTime":1690810200000,"name":"Bristol-Myers Squibb Co.","recordDate":"2023-09-01","payableDate":"2023-08-01","currency":"USD","dateTimestamp":1690776000000,"payDate":"2023-09-01"},{"market":"US","date":"2023-05-01","symbol":"BMYMP","amount":0.5,"defaultRemindTime":1682947800000,"name":"Bristol-Myers Squibb Co.","recordDate":"2023-06-01","payableDate":"2023-05-02","currency":"USD","type":"dividend","dateTimestamp":1682913600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMYMP\",market:\"US\",,,undefined,":[{"executeDate":"2019-02-04","recordDate":"2019-02-05","paymentDate":"2019-03-01","value":0.5,"currency":"USD"},{"executeDate":"2019-05-06","recordDate":"2019-05-07","paymentDate":"2019-06-03","value":0.5,"currency":"USD"},{"executeDate":"2019-08-05","recordDate":"2019-08-06","paymentDate":"2019-09-03","value":0.5,"currency":"USD"},{"executeDate":"2019-11-04","recordDate":"2019-11-05","paymentDate":"2019-12-02","value":0.5,"currency":"USD"},{"executeDate":"2020-02-03","recordDate":"2020-02-04","paymentDate":"2020-03-02","value":0.5,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMYMP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.bms.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":-0.0676},{"period":"6month","weight":-0.0418},{"period":"1year","weight":-0.225},{"period":"ytd","weight":-0.0864}],"description":"百時美施貴寶公司於1933年8月根據特拉華州法律註冊成立，名為百時美公司，繼承了1887年在紐約成立的一家企業。1989年，由於合併，公司更名為百時美施貴寶公司。該公司在全球範圍內從事生物製藥產品的發現、開發、許可、製造、營銷、分銷和銷售。該公司預計，對Celgene和MyoKardia的收購將進一步將公司定位為領先的生物製藥公司，通過幾項近期資產和額外的外部合作夥伴關係擴大其腫瘤學、血液學、免疫學和心血管領域的投資組合。","exchange":"PINK LIMITED","name":"Bristol-Myers Squibb Co.","nameEN":"Bristol-Myers Squibb Co."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BMYMP\",market:\"US\",,,undefined,":null}}